American Society of Hirudotherapy

Delayed-onset, persisting autoimmune heparin-induced thrombocytopenia with thrombosis following craniofacial surgery

Case report published in BMJ Case Reports (2026)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportClinical LiteratureDrug DevelopmentWill VJ et al. · BMJ Case Reports, 2026

Abstract

We report a case of a patient who developed delayed-onset, persisting autoimmune heparin-induced thrombocytopenia (HIT) following prophylactic anticoagulation with unfractionated heparin (UFH) after surgical treatment of a complex midfacial and mandibular fracture. Four days after stopping prophylactic anticoagulation, the patient developed pulmonary embolism and mild thrombocytopenia. HIT was initially not suspected and therapeutic anticoagulation was started. The patient subsequently developed severe thrombocytopenia consistent with HIT. Despite cessation of UFH and initiation of argatroban, thrombocytopenia did not improve. A HIT-antibody immunoassay and functional assay (HIPA) was strongly positive, and HIPA showed activity even in the absence of heparin, supporting the diagnosis of delayed-onset, persisting autoimmune HIT (aHIT). The patient was treated with immunoglobulin, resulting in a rapid recovery of platelet counts. This case highlights the importance of early recognition and appropriate management of aHIT, especially in patients with persisting thrombocytopenia despite standard HIT therapy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleCase Reports
Indexed MeSH termsHumansAnticoagulantsArginineHeparinMandibular FracturesPostoperative ComplicationsPulmonary EmbolismPurpura, Thrombocytopenic, IdiopathicSulfonamidesThrombocytopeniaThrombosis

Summary

A patient developed delayed-onset, persisting autoimmune HIT after heparin prophylaxis for craniofacial fracture surgery; thrombocytopenia did not improve after stopping heparin and starting argatroban, but platelet counts recovered rapidly after treatment with immunoglobulin, and HIPA activity persisted even without heparin.

Context

This case report describes a patient who developed delayed-onset, persisting autoimmune heparin-induced thrombocytopenia (aHIT) with thrombosis following prophylactic unfractionated heparin after surgical treatment of a complex midfacial and mandibular fracture, with pulmonary embolism and severe thrombocytopenia developing despite cessation of UFH and initiation of argatroban. A strongly positive HIPA assay showing activity even in the absence of heparin supported the aHIT diagnosis, and treatment with immunoglobulin resulted in rapid platelet recovery. The abstract makes no mention of hirudin, lepirudin, leeches, or any leech-derived therapy. It contains no leech-related content. CAVEAT: This is a single case report focused on autoimmune HIT pathogenesis and immunomodulatory treatment; it contains no leech-related content.

Citation

Reference (Vancouver style)

Will VJ, Tritschler T, Marx CE. Delayed-onset, persisting autoimmune heparin-induced thrombocytopenia with thrombosis following craniofacial surgery. BMJ Case Rep. 2026;19(2):e269479. doi:10.1136/bcr-2025-269479. PMID: 41692486

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.